On the public citation graph
Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)
0 signed · 563 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
inferredcites →https://doi.org/10.1056/nejmoa2001191openalex-snapshot
First Case of 2019 Novel Coronavirus in the United States
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/aid2.13260openalex-snapshot
COVID ‐19 complications on the digestive system and liver: A current clinical and pathophysiological approach
inferred← citeshttps://doi.org/10.1002/brb3.1839openalex-snapshot
Can symptoms of anosmia and dysgeusia be diagnostic for COVID‐19?
inferred← citeshttps://doi.org/10.1002/cam4.3692openalex-snapshot
The effect of anticancer treatment on cancer patients with COVID‐19: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/cti2.1204openalex-snapshot
Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19
inferred← citeshttps://doi.org/10.1002/ddr.21717openalex-snapshot
TWIRLS , a knowledge‐mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2
inferred← citeshttps://doi.org/10.1002/ddr.21720openalex-snapshot
Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus‐2 disease: COVID ‐19
inferred← citeshttps://doi.org/10.1002/ddr.21895openalex-snapshot
Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
inferred← citeshttps://doi.org/10.1002/ehf2.12960openalex-snapshot
Crosstalk Between Coronavirus Disease 2019 and Cardiovascular Disease and Its Treatment
inferred← citeshttps://doi.org/10.1002/eji.202049163openalex-snapshot
Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients
inferred← citeshttps://doi.org/10.1002/jcla.24152openalex-snapshot
Coronavirus Disease 2019 (COVID‐19): Emerging detection technologies and auxiliary analysis
inferred← citeshttps://doi.org/10.1002/jcp.29802openalex-snapshot
Single‐cell RNA analysis on ACE2 expression provides insights into SARS‐CoV‐2 potential entry into the bloodstream and heart injury
inferred← citeshttps://doi.org/10.1002/jcp.29804openalex-snapshot
The outlook for diagnostic purposes of the 2019‐novel coronavirus disease
inferred← citeshttps://doi.org/10.1002/jcp.30041openalex-snapshot
ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID‐19
inferred← citeshttps://doi.org/10.1002/jcp.30047openalex-snapshot
Expression of Concern: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls
inferred← citeshttps://doi.org/10.1002/jcp.30076openalex-snapshot
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
inferred← citeshttps://doi.org/10.1002/jlb.3covr0520-272ropenalex-snapshot
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
inferred← citeshttps://doi.org/10.1002/jmv.25770openalex-snapshot
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
inferred← citeshttps://doi.org/10.1002/jmv.25783openalex-snapshot
Clinical features and treatment of COVID‐19 patients in northeast Chongqing
inferred← citeshttps://doi.org/10.1002/jmv.26473openalex-snapshot
Evaluation of 17 patients with COVID‐19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA, and Brescia‐COVID respiratory severity scale (BCRSS) scoring systems
inferred← citeshttps://doi.org/10.1002/jmv.26727openalex-snapshot
Administration of intravenous immunoglobulin in the treatment of COVID‐19: A review of available evidence
inferred← citeshttps://doi.org/10.1002/jmv.27112openalex-snapshot
Relative expression of proinflammatory molecules in COVID‐19 patients who manifested disease severities
inferred← citeshttps://doi.org/10.1002/jmv.27127openalex-snapshot
Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID‐2019) in 23 countries
inferred← citeshttps://doi.org/10.1002/mco2.154openalex-snapshot
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
inferred← citeshttps://doi.org/10.1002/rmv.2168openalex-snapshot
SARS‐CoV‐2: Mechanism of infection and emerging technologies for future prospects
inferred← citeshttps://doi.org/10.1002/rmv.2183openalex-snapshot
Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects
inferred← citeshttps://doi.org/10.1002/rmv.2195openalex-snapshot
A systematic meta‐analysis of immune signatures in patients with COVID‐19
inferred← citeshttps://doi.org/10.1007/978-3-030-63761-3_22openalex-snapshot
Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in COVID-19: A Multisystem Disease
inferred← citeshttps://doi.org/10.1007/978-3-030-70115-4_12openalex-snapshot
The Importance of Glycosylation in COVID-19 Infection
inferred← citeshttps://doi.org/10.1007/978-3-030-87978-5_8openalex-snapshot
COVID-19 Pathophysiology and COVID-19-Induced Respiratory Failure
inferred← citeshttps://doi.org/10.1007/978-3-030-90065-6_7openalex-snapshot
Overview of Cytokines and CoViD19
inferred← citeshttps://doi.org/10.1007/978-981-33-6850-7_20openalex-snapshot
COVID-19 Pandemic Panic: Prophylactic as Well as Therapeutic Management with Traditional Ethnic Phytopharmaceuticals with Challenging Nano-spray Inhaler and Advanced Drug Delivery System
inferred← citeshttps://doi.org/10.1007/s00011-021-01445-2openalex-snapshot
Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection
inferred← citeshttps://doi.org/10.1007/s00011-022-01543-9openalex-snapshot
Cytokine producing ability of peripheral blood cells from COVID-19 patients after unspecific in vitro stimulation
inferred← citeshttps://doi.org/10.1007/s00109-020-01927-6openalex-snapshot
Novel therapeutic approaches for treatment of COVID-19
inferred← citeshttps://doi.org/10.1007/s00284-022-03003-3openalex-snapshot
Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development
inferred← citeshttps://doi.org/10.1007/s00296-021-04818-2openalex-snapshot
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
inferred← citeshttps://doi.org/10.1007/s00403-020-02156-0openalex-snapshot
Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations
inferred← citeshttps://doi.org/10.1007/s00604-022-05167-yopenalex-snapshot
A review on corona virus disease 2019 (COVID-19): current progress, clinical features and bioanalytical diagnostic methods
inferred← citeshttps://doi.org/10.1007/s00705-021-05036-8openalex-snapshot
The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)
inferred← citeshttps://doi.org/10.1007/s10067-024-07033-zopenalex-snapshot
Systematic analysis for clinical characteristics and outcomes of IgG4-related disease patients during the COVID-19 pandemic
inferred← citeshttps://doi.org/10.1007/s10072-022-05875-6openalex-snapshot
Neurological toll of COVID-19
inferred← citeshttps://doi.org/10.1007/s10147-020-01837-0openalex-snapshot
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan
inferred← citeshttps://doi.org/10.1007/s10554-021-02228-wopenalex-snapshot
Evaluation the relationship of left ventricular global longitudinal strain and laboratory parameters in discharged patients with COVID-19: a follow-up study
inferred← citeshttps://doi.org/10.1007/s10559-024-00730-2openalex-snapshot
Mathematical Modeling of the T-Cell Immune Response in Covid-19
inferred← citeshttps://doi.org/10.1007/s10741-021-10087-9openalex-snapshot
COVID-19 and myocarditis: a systematic review and overview of current challenges
inferred← citeshttps://doi.org/10.1007/s11010-020-04004-1openalex-snapshot
COVID-19: advance in laboratory diagnostic strategy and technology
inferred← citeshttps://doi.org/10.1007/s11010-022-04610-1openalex-snapshot
Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise
inferred← citeshttps://doi.org/10.1007/s11126-022-09980-9openalex-snapshot
COVID-19 and its impact on the brain and Mind- A conceptual model and supporting evidence
inferred← citeshttps://doi.org/10.1007/s11239-020-02224-2openalex-snapshot
COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness
inferred← citeshttps://doi.org/10.1007/s11845-021-02740-xopenalex-snapshot
The relationship between mortality and inflammatory markers and the systemic immune inflammatory index in patients in the intensive care unit with a pneumothorax as a complication of COVID-19 disease
inferred← citeshttps://doi.org/10.1007/s11908-020-00738-7openalex-snapshot
Clinical Challenges in an Outbreak of COVID-19 in Wuhan, China: Concerns from Frontiers
inferred← citeshttps://doi.org/10.1007/s12011-021-02797-wopenalex-snapshot
Decreased Serum Selenium Levels of COVID-19 Patients in Comparison with Healthy Individuals
inferred← citeshttps://doi.org/10.1007/s12016-020-08797-3openalex-snapshot
COVID-19 and Asthma: Reflection During the Pandemic
inferred← citeshttps://doi.org/10.1007/s12020-020-02444-9openalex-snapshot
Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review
inferred← citeshttps://doi.org/10.1007/s12031-020-01767-6openalex-snapshot
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations
inferred← citeshttps://doi.org/10.1007/s12035-020-02072-4openalex-snapshot
Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic
inferred← citeshttps://doi.org/10.1007/s12035-023-03632-0openalex-snapshot
A Promising Drug Candidate as Potent Therapeutic Approach for Neuroinflammation and Its In Silico Justification of Chalcone Congeners: a Comprehensive Review
inferred← citeshttps://doi.org/10.1007/s13205-021-02685-zopenalex-snapshot
Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α
inferred← citeshttps://doi.org/10.1007/s13238-020-00768-wopenalex-snapshot
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
inferred← citeshttps://doi.org/10.1007/s13337-023-00820-3openalex-snapshot
SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight
inferred← citeshttps://doi.org/10.1007/s40139-021-00228-yopenalex-snapshot
The Pathobiological Basis for Thrombotic Complications in COVID-19: a Review of the Literature
inferred← citeshttps://doi.org/10.1007/s40261-020-00917-3openalex-snapshot
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
inferred← citeshttps://doi.org/10.1007/s40521-020-00258-8openalex-snapshot
A Precision Medicine Approach to SARS-CoV-2 Pandemic Management
inferred← citeshttps://doi.org/10.1007/s40843-025-3723-4openalex-snapshot
Advances in hydrogen therapy and hydrogen administration biomaterials for respiratory diseases
inferred← citeshttps://doi.org/10.1007/s40883-021-00202-5openalex-snapshot
Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19
inferred← citeshttps://doi.org/10.1007/s42398-021-00204-7openalex-snapshot
Novel coronavirus disease (COVID-19): origin, transmission through the environment, health effects, and mitigation strategies—a review
inferred← citeshttps://doi.org/10.1007/s42399-020-00364-3openalex-snapshot
Coronavirus Disease of 2019: a Mimicker of Dengue Infection?
inferred← citeshttps://doi.org/10.1007/s42399-020-00399-6openalex-snapshot
Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials
inferred← citeshttps://doi.org/10.1007/s43393-022-00091-xopenalex-snapshot
Intra-protein interactions of SARS-CoV-2 and SARS: a bioinformatic analysis for plausible explanation regarding stability, divergency, and severity
inferred← citeshttps://doi.org/10.1007/s43465-020-00121-7openalex-snapshot
Is Immuno-modulation the Key to COVID-19 Pandemic?
inferred← citeshttps://doi.org/10.1016/b978-0-323-82691-4.00006-6openalex-snapshot
Neuropathogenesis of SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.1016/b978-0-323-89861-4.00001-4openalex-snapshot
COVID-19: An analysis on official reports in Iran and the world along with some comparisons to other hazards
inferred← citeshttps://doi.org/10.1016/b978-0-323-89972-7.00011-8openalex-snapshot
Current strategies and future perspectives in COVID-19 therapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-32930-2.00012-xopenalex-snapshot
Laboratory test and other tests
inferred← citeshttps://doi.org/10.1016/j.abst.2022.10.001openalex-snapshot
Biomarkers of sequela in adult patients convalescing from COVID-19
inferred← citeshttps://doi.org/10.1016/j.addr.2020.12.011openalex-snapshot
COVID-19 vaccines: The status and perspectives in delivery points of view
inferred← citeshttps://doi.org/10.1016/j.ajem.2020.05.024openalex-snapshot
Neurologic complications of COVID-19
inferred← citeshttps://doi.org/10.1016/j.ajp.2020.102350openalex-snapshot
Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses
inferred← citeshttps://doi.org/10.1016/j.arcmed.2020.06.012openalex-snapshot
Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review
inferred← citeshttps://doi.org/10.1016/j.arr.2022.101818openalex-snapshot
Immunosenescence and inflamm-ageing in COVID-19
inferred← citeshttps://doi.org/10.1016/j.autrev.2020.102523openalex-snapshot
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
inferred← citeshttps://doi.org/10.1016/j.autrev.2020.102537openalex-snapshot
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
inferred← citeshttps://doi.org/10.1016/j.autrev.2020.102554openalex-snapshot
Convalescent plasma in Covid-19: Possible mechanisms of action
inferred← citeshttps://doi.org/10.1016/j.autrev.2020.102567openalex-snapshot
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
inferred← citeshttps://doi.org/10.1016/j.autrev.2020.102568openalex-snapshot
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
inferred← citeshttps://doi.org/10.1016/j.bbadis.2020.165889openalex-snapshot
SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.bbi.2020.03.031openalex-snapshot
Nervous system involvement after infection with COVID-19 and other coronaviruses
inferred← citeshttps://doi.org/10.1016/j.bbi.2020.05.037openalex-snapshot
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
inferred← citeshttps://doi.org/10.1016/j.bbi.2020.05.054openalex-snapshot
Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report
inferred← citeshttps://doi.org/10.1016/j.bioorg.2024.107977openalex-snapshot
A Glimpse for the subsistence from pandemic SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/j.biopha.2020.110195openalex-snapshot
New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112420openalex-snapshot
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.bsheal.2021.01.001openalex-snapshot
Review of pharmacologic and immunologic agents in the management of COVID-19
inferred← citeshttps://doi.org/10.1016/j.carpath.2020.107228openalex-snapshot
Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019
inferred← citeshttps://doi.org/10.1016/j.ccmp.2022.100021openalex-snapshot
Herbal Remedies, Nutraceuticals, and Dietary Supplements for COVID-19 Management: An Update
inferred← citeshttps://doi.org/10.1016/j.clim.2020.108393openalex-snapshot
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
inferred← citeshttps://doi.org/10.1016/j.clim.2020.108615openalex-snapshot
An enlightening role for cytokine storm in coronavirus infection
inferred← citeshttps://doi.org/10.1016/j.crphar.2021.100064openalex-snapshot
The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response
inferred← citeshttps://doi.org/10.1016/j.cyto.2020.155302openalex-snapshot
Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19
inferred← citeshttps://doi.org/10.1016/j.cyto.2020.155389openalex-snapshot
Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2020.05.001openalex-snapshot
Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2020.06.001openalex-snapshot
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2020.06.012openalex-snapshot
A critical evaluation of glucocorticoids in the management of severe COVID-19
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2020.10.002openalex-snapshot
Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19
inferred← citeshttps://doi.org/10.1016/j.dsx.2020.05.022openalex-snapshot
Angiotensin converting enzyme-2 as therapeutic target in COVID-19
inferred← citeshttps://doi.org/10.1016/j.eng.2020.08.009openalex-snapshot
The Scientific Foundation of Chinese Herbal Medicine against COVID-19
inferred← citeshttps://doi.org/10.1016/j.eng.2021.09.007openalex-snapshot
Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response
inferred← citeshttps://doi.org/10.1016/j.etap.2022.103937openalex-snapshot
Can iron, zinc, copper and selenium status be a prognostic determinant in COVID-19 patients?
inferred← citeshttps://doi.org/10.1016/j.gendis.2023.101167openalex-snapshot
SARS-CoV-2 triggers Dickkopf-1 (Dkk-1) modulation of T helper cells and lung pathology in mice
inferred← citeshttps://doi.org/10.1016/j.heliyon.2021.e06158openalex-snapshot
Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e20590openalex-snapshot
Incompetent memory immune response in severe COVID-19 patients under treatment
inferred← citeshttps://doi.org/10.1016/j.humimm.2021.06.011openalex-snapshot
Humoral immune mechanisms involved in protective and pathological immunity during COVID-19
inferred← citeshttps://doi.org/10.1016/j.humimm.2023.05.003openalex-snapshot
Combining nano-curcumin with catechin improves COVID-19-infected patient's inflammatory conditions
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2020.105948openalex-snapshot
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
inferred← citeshttps://doi.org/10.1016/j.ijid.2020.06.059openalex-snapshot
Relationship between chest CT manifestations and immune response in COVID-19 patients
inferred← citeshttps://doi.org/10.1016/j.ijid.2020.06.080openalex-snapshot
Nocturnal oxygen therapy as an option for early COVID-19
inferred← citeshttps://doi.org/10.1016/j.immuni.2020.05.002openalex-snapshot
Immunology of COVID-19: Current State of the Science
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.106749openalex-snapshot
Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.106885openalex-snapshot
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.106928openalex-snapshot
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.106947openalex-snapshot
Drug repurposing and cytokine management in response to COVID-19: A review
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.107156openalex-snapshot
Exploring the multifocal therapeutic approaches in COVID-19: A ray of hope
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107569openalex-snapshot
The role of IL-6/lymphocyte ratio in the peripheral blood of severe patients with COVID-19
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107828openalex-snapshot
Different T cell related immunological profiles in COVID-19 patients compared to healthy controls
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.109161openalex-snapshot
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine
inferred← citeshttps://doi.org/10.1016/j.jaci.2020.07.001openalex-snapshot
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/j.jacl.2020.12.008openalex-snapshot
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy
inferred← citeshttps://doi.org/10.1016/j.jcv.2020.104370openalex-snapshot
Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
inferred← citeshttps://doi.org/10.1016/j.jep.2021.113854openalex-snapshot
Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification
inferred← citeshttps://doi.org/10.1016/j.jff.2024.106561openalex-snapshot
Application and mechanism of natural products and nutrient elements in COVID-19
inferred← citeshttps://doi.org/10.1016/j.jgr.2023.04.002openalex-snapshot
The potential of Panax notoginseng against COVID-19 infection
inferred← citeshttps://doi.org/10.1016/j.jinf.2020.03.004openalex-snapshot
Clinical progression of patients with COVID-19 in Shanghai, China
inferred← citeshttps://doi.org/10.1016/j.jinf.2020.03.037openalex-snapshot
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
inferred← citeshttps://doi.org/10.1016/j.jmii.2021.07.010openalex-snapshot
Neurological manifestations in COVID-19 patients and their application in predicting fatal disease: A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2020.577436openalex-snapshot
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation
inferred← citeshttps://doi.org/10.1016/j.jocn.2021.07.023openalex-snapshot
Investigating the potential mechanisms of depression induced-by COVID-19 infection in patients
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118054openalex-snapshot
Tackling the cytokine storm in COVID-19, challenges and hopes
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118167openalex-snapshot
The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118170openalex-snapshot
Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118336openalex-snapshot
COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118474openalex-snapshot
Influence of dabigatran on pro-inflammatory cytokines, growth factors and chemokines – Slowing the vicious circle of coagulation and inflammation
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118496openalex-snapshot
Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118923openalex-snapshot
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.120267openalex-snapshot
Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy
inferred← citeshttps://doi.org/10.1016/j.mayocpiqo.2020.07.004openalex-snapshot
A Narrative Review of Emerging Therapeutics for COVID-19
inferred← citeshttps://doi.org/10.1016/j.mbm.2024.100063openalex-snapshot
Bead-based microfluidic platforms for multiplex and ultrasensitive immunoassays in clinical diagnosis and treatment
inferred← citeshttps://doi.org/10.1016/j.medcle.2020.06.003openalex-snapshot
Supportive treatment of COVID 19 patients with mild respiratory failure in a primary hospital
inferred← citeshttps://doi.org/10.1016/j.mehy.2020.109842openalex-snapshot
Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?
inferred← citeshttps://doi.org/10.1016/j.mehy.2020.110102openalex-snapshot
SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression
inferred← citeshttps://doi.org/10.1016/j.metabol.2020.154282openalex-snapshot
Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
inferred← citeshttps://doi.org/10.1016/j.nbscr.2020.100057openalex-snapshot
COVID-19-associated sleep disorders: A case report
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2021.05.008openalex-snapshot
Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19
inferred← citeshttps://doi.org/10.1016/j.npbr.2020.10.001openalex-snapshot
Seizure and COVID-19: Association and review of potential mechanism
inferred← citeshttps://doi.org/10.1016/j.pcd.2020.08.018openalex-snapshot
COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine
inferred← citeshttps://doi.org/10.1016/j.phrs.2020.104761openalex-snapshot
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
inferred← citeshttps://doi.org/10.1016/j.phrs.2020.104946openalex-snapshot
Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications
inferred← citeshttps://doi.org/10.1016/j.phymed.2020.153279openalex-snapshot
Contribution of traditional Chinese medicine to the treatment of COVID-19
inferred← citeshttps://doi.org/10.1016/j.phymed.2021.153874openalex-snapshot
Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action
inferred← citeshttps://doi.org/10.1016/j.rcreu.2020.09.005openalex-snapshot
Síndrome inflamatorio multisistémico en niños con COVID-19: una visión desde la reumatología
inferred← citeshttps://doi.org/10.1016/j.rcreue.2020.09.004openalex-snapshot
Multisystemic inflammatory syndrome in children with COVID-19: A rheumatology perspective
inferred← citeshttps://doi.org/10.1016/j.redox.2020.101715openalex-snapshot
Selenium and selenoproteins in viral infection with potential relevance to COVID-19
inferred← citeshttps://doi.org/10.1016/j.resp.2020.103548openalex-snapshot
Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes
inferred← citeshttps://doi.org/10.1016/j.reuma.2020.05.002openalex-snapshot
Opciones terapéuticas en el manejo de la COVID-19 grave: una perspectiva de Reumatología
inferred← citeshttps://doi.org/10.1016/j.reumae.2020.05.002openalex-snapshot
Therapeutic options for the management of severe COVID-19: A rheumatology perspective
inferred← citeshttps://doi.org/10.1016/j.rmcr.2020.101319openalex-snapshot
Post-transplant patients with COVID-19 associated acute respiratory distress syndrome, a role for Tociluzumab: A case series
inferred← citeshttps://doi.org/10.1016/j.tacc.2020.07.004openalex-snapshot
Emerging patterns of hypercoagulability associated with critical COVID-19: A review
inferred← citeshttps://doi.org/10.1016/j.tem.2020.10.001openalex-snapshot
Cardiovascular Manifestations and Mechanisms in Patients with COVID-19
inferred← citeshttps://doi.org/10.1016/j.transci.2020.102850openalex-snapshot
Anti-SARS-CoV-2 hyperimmune plasma workflow
inferred← citeshttps://doi.org/10.1016/j.transci.2020.102855openalex-snapshot
Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption
inferred← citeshttps://doi.org/10.1016/j.virusres.2022.198962openalex-snapshot
SARS-CoV-2 mediated dysregulation in cell signaling events drives the severity of COVID-19
inferred← citeshttps://doi.org/10.1016/j.ymthe.2021.10.014openalex-snapshot
The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
inferred← citeshttps://doi.org/10.1016/j.ymthe.2022.03.014openalex-snapshot
Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics
inferred← citeshttps://doi.org/10.1016/s2213-2600(20)30404-5openalex-snapshot
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
inferred← citeshttps://doi.org/10.1016/s2213-2600(21)00103-xopenalex-snapshot
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
inferred← citeshttps://doi.org/10.1016/s2665-9913(20)30120-xopenalex-snapshot
The immunology of COVID-19: is immune modulation an option for treatment?
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.0c01287openalex-snapshot
Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
inferred← citeshttps://doi.org/10.1021/acschemneuro.0c00446openalex-snapshot
Brain and COVID-19 Crosstalk: Pathophysiological and Psychological Manifestations
inferred← citeshttps://doi.org/10.1021/acschemneuro.0c00447openalex-snapshot
Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6
inferred← citeshttps://doi.org/10.1021/acschemneuro.1c00353openalex-snapshot
Neurological Manifestations in COVID-19 Patients: A Meta-Analysis
inferred← citeshttps://doi.org/10.1037/neu0000731openalex-snapshot
Neuropsychology of COVID-19: Anticipated cognitive and mental health outcomes.
inferred← citeshttps://doi.org/10.1038/s41366-020-0602-yopenalex-snapshot
Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection
inferred← citeshttps://doi.org/10.1038/s41392-020-00243-2openalex-snapshot
COVID-19: immunopathogenesis and Immunotherapeutics
inferred← citeshttps://doi.org/10.1038/s41392-020-0191-1openalex-snapshot
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
inferred← citeshttps://doi.org/10.1038/s41392-021-00679-0openalex-snapshot
The signal pathways and treatment of cytokine storm in COVID-19
inferred← citeshttps://doi.org/10.1038/s41419-020-03151-zopenalex-snapshot
Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients
inferred← citeshttps://doi.org/10.1038/s41419-020-2636-4openalex-snapshot
The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia
inferred← citeshttps://doi.org/10.1038/s41536-021-00147-xopenalex-snapshot
Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19
inferred← citeshttps://doi.org/10.1038/s43587-021-00114-7openalex-snapshot
SARS-CoV-2, COVID-19 and the aging immune system
inferred← citeshttps://doi.org/10.1039/d1ra07988copenalex-snapshot
Insight into prognostics, diagnostics, and management strategies for SARS CoV-2
inferred← citeshttps://doi.org/10.1042/etls20200165openalex-snapshot
How SARS-CoV-2 (COVID-19) spreads within infected hosts — what we know so far
inferred← citeshttps://doi.org/10.1055/s-0040-1717833openalex-snapshot
Neurological Problems in COVID-19 Pandemic
inferred← citeshttps://doi.org/10.1055/s-0041-1729781openalex-snapshot
Role of ACE 2 and Vitamin D: The Two Players in Global Fight against COVID-19 Pandemic
inferred← citeshttps://doi.org/10.1073/pnas.2006691117openalex-snapshot
Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19
inferred← citeshttps://doi.org/10.1080/00365513.2021.1892817openalex-snapshot
The understanding of the immunopathology in COVID-19 infection
inferred← citeshttps://doi.org/10.1080/03007995.2021.1906637openalex-snapshot
COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies
inferred← citeshttps://doi.org/10.1080/03009742.2020.1789734openalex-snapshot
Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome
inferred← citeshttps://doi.org/10.1080/03639045.2020.1826510openalex-snapshot
Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus pneumonia (COVID-19)
inferred← citeshttps://doi.org/10.1080/08830185.2021.1884248openalex-snapshot
Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality
inferred← citeshttps://doi.org/10.1080/14712598.2022.2078160openalex-snapshot
Therapeutic monoclonal antibodies for COVID-19 management: an update
inferred← citeshttps://doi.org/10.1080/14787210.2020.1822737openalex-snapshot
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up
showing the first 200 of 561 · page through all 561
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.